Latest Breaking News On - Breast oncology program at duke university - Page 1 : comparemela.com

The FDA's Medical Imaging Drugs Advisory Committee voted 16 to 2 in support of the benefit-risk profile of Lumisight.

Shelley hwangJorge ferrerBreast oncology program at duke universityImaging drugs advisory committeeLumicell incLumicell direct visualization systemBreast oncology programDuke university